Pharmaceutical giant AbbVie Inc said it was reevaluating its planned  billion acquisition of Shire PLC in light of new US rules making it harder for American companies to lower taxes through overseas deal making The rethink is the most dramatic fallout so far from a broad crackdown by Washington on socalled inversionstakeover deals structured to relocate tax domiciles of US companies overseas to capture tax benefits 